CGS in the News

The legacy of eugenics

By Sheila Kaplan, UC Berkeley School of Public Health | 06.20.2024

These days, it’s a rare scientist who would admit to working in eugenics.

The word conjures historical horrors: mass sterilization of people judged unfit to reproduce, state anti-miscegenation laws, and Germany’s justification for the...

Human Genetic Modification

Biopolitical Times on CIRM's 'Depressingly Small Number of Effective Treatments or Cures'

By David Jensen [cites CGS' Pete Shanks], The California Stem Cell Report | 06.24.2024

_{Image by NIH Image Gallery from Flickr}

The Biopolitical Times reported this month that the California stem cell and gene therapy program “seems to be in serious trouble.”

“On first glance, it may look impressive, with over a thousand patients...

Stem Cells

California Stem Cell Measure Scrutinized in Virus Budget Crunch

By Joyce E. Cutler and Tiffany Stecker, Bloomberg Government | 09.17.2020

California voters will be asked this November to spend big on stem cell research, an expensive proposition that could help...

Policies

Strict new guidelines lay out a path to heritable human gene editing

By Tina Hesman Saey, Science News [cites CGS's Katie Hasson] | 09.03.2020

^{In 2018, Jiankui He (pictured) announced that he had edited genes in embryos to create two baby girls.}

Gene editing...

Policies

Genome editing for heritable diseases not yet safe, report states

By Ian Sample, The Guardian [cites CGS' Marcy Darnovsky] | 09.03.2020

Powerful genome editing procedures that could prevent parents from passing on heritable diseases to their children are far from ready...

Human Genetic Modification

Landmark Privacy Proposal To Give Consumers Control Over Their Genetic Data Advances To Governor Newsom’s Desk For Signature

By George Thomas, The Government Center Gazette [cites CGS] | 09.01.2020

SACRAMENTO, CA — Senator Thomas J. Umberg (D-Santa Ana) announced today that his measure, Senate Bill 980 (SB 980) passed the California...

Policies

$5.5 billion stem cell rescue plan makes November ballot

By David Jensen, Capitol Weekly [cites CGS and Marcy Darnovsky] | 06.22.2020

A $5.5 billion stem cell bond measure qualified this afternoon for the November ballot, but the campaign to win voter...

Stem Cells

Doha Debates turns spotlight on future of genetics

By Anon, Gulf Times [cites CGS' Katie Hasson] | 03.27.2020

The question of where the line should be drawn in human gene editing, and if it should be allowed to...

Human Genetic Modification

white baby crawling on a green background

Designer Babies: Rogue Science or Future Option?

By Dolli Player and Alicia Matsuura, The Daily Universe [Cites CGS' Marcy Darnovsky] | 02.18.2020

In the early 2000s, genome editing seemed like the answer to parents who carried latent genes that could result in...

Human Genetic Modification

latex gloves and a home DNA test swab and vial

Layoffs Result as Consumers Think Twice About DNA Testing

By David Lazarus , Los Angeles Times [Cites CGS' Marcy Darnovsky] | 02.10.2020

These have been rough days for the DNA-testing business — an industry that sprang up seemingly overnight with promises of...

Genomics